Status:
SUSPENDED
Acetic Acid for the Detection of Esophageal Neoplasms
Lead Sponsor:
Coordinación de Investigación en Salud, Mexico
Conditions:
Barretts Esophagus With Low Grade Dysplasia
Dysplasia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Barrett's esophagus is a complication of chronic gastroesophageal reflux disease that occurs in up to 10% to 15% of patients with this pathology. Well-defined risk factors have been established and ar...
Detailed Description
Barrett's esophagus is a complication of chronic gastroesophageal reflux disease that occurs in up to 10 to 15% of patients with this disease, well-defined risk factors have been established and are i...
Eligibility Criteria
Inclusion
- Confirmed histological diagnosis of intestinal metaplasia in follow-up protocol without dysplasia
- Patients whose endoscopic image is suggestive of esophageal intestinal metaplasia and is confirmed by histology
- Barrett's esophagus minimally 2cm
- Patients over 18 years of age who wish to participate in the study
- Signed informed consent
Exclusion
- Histological evidence of esophageal adenocarcinoma or known with dysplasia
- History of esophageal ablative therapy
- Known allergy or intolerance to proton pump inhibitors or acetic acid
- Evidence of esophageal varices
- Los Angeles esophagitis C or D
- Uncontrolled coagulopathy (INR\> 1.5 or platelets \<50,000)
- Pregnancy
- No authorization of informed consent
Key Trial Info
Start Date :
July 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT04054713
Start Date
July 3 2019
End Date
May 1 2025
Last Update
April 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Medico Nacional Siglo XXI Hospital de Especialidades
Mexico City, Mexico City, Mexico, 06700